FI963674A - Yhdistelmä-DNA-adenoviruksia, jotka koodittavat aivoperäistä neurotrofista tekijää (BDNF) - Google Patents

Yhdistelmä-DNA-adenoviruksia, jotka koodittavat aivoperäistä neurotrofista tekijää (BDNF) Download PDF

Info

Publication number
FI963674A
FI963674A FI963674A FI963674A FI963674A FI 963674 A FI963674 A FI 963674A FI 963674 A FI963674 A FI 963674A FI 963674 A FI963674 A FI 963674A FI 963674 A FI963674 A FI 963674A
Authority
FI
Finland
Prior art keywords
bdnf
recombinant dna
neurotrophic factor
adenoviruses encoding
brain neurotrophic
Prior art date
Application number
FI963674A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963674A0 (fi
Inventor
Pascal Barneoud
Pia Delaere
Michel Perricaudet
Laurent Pradier
Emmanuelle Vigne
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI963674A publication Critical patent/FI963674A/fi
Publication of FI963674A0 publication Critical patent/FI963674A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Plant Pathology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI963674A 1994-03-18 1996-09-17 Yhdistelmä-DNA-adenoviruksia, jotka koodittavat aivoperäistä neurotrofista tekijää (BDNF) FI963674A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9403191A FR2717496B1 (fr) 1994-03-18 1994-03-18 Virus recombinants, préparation et utilisation en thérapie génique.
PCT/FR1995/000250 WO1995025804A1 (fr) 1994-03-18 1995-03-02 Adenovirus recombinants codant pour le facteur neurotrophique derive du cerveau (bdnf)

Publications (2)

Publication Number Publication Date
FI963674A true FI963674A (fi) 1996-09-17
FI963674A0 FI963674A0 (fi) 1996-09-17

Family

ID=9461190

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963674A FI963674A0 (fi) 1994-03-18 1996-09-17 Yhdistelmä-DNA-adenoviruksia, jotka koodittavat aivoperäistä neurotrofista tekijää (BDNF)

Country Status (12)

Country Link
EP (1) EP0750676A1 (ja)
JP (1) JPH09510358A (ja)
KR (1) KR970701784A (ja)
AU (1) AU703793B2 (ja)
CA (1) CA2184200A1 (ja)
FI (1) FI963674A0 (ja)
FR (1) FR2717496B1 (ja)
IL (1) IL112992A0 (ja)
MX (1) MX9603490A (ja)
NO (1) NO963559L (ja)
WO (1) WO1995025804A1 (ja)
ZA (1) ZA952244B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830857A (en) * 1995-07-14 1998-11-03 Amgen Inc. Method of treating epilepsy
FR2753379B1 (fr) * 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa Methode de traitement de la sclerose laterale amyotrophique
AU5945301A (en) * 2000-05-05 2001-11-20 Res Foundation Of City Univers Methods for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis
US20210079050A1 (en) * 2018-02-20 2021-03-18 Carmel Haifa University Economic Corporation Ltd. Compositions and methods for delivery and expression of small inhibitory peptides and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU675409B2 (en) * 1991-07-10 1997-02-06 Regeneron Pharmaceuticals, Inc. Methods of treatment of motor neuron diseases using members of the BDNF/NT-3/NGF family of molecules
AU3129793A (en) * 1991-11-08 1993-06-07 General Hospital Corporation, The Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration
FR2688514A1 (fr) * 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
AU4995193A (en) * 1992-08-04 1994-03-03 Regeneron Pharmaceuticals, Inc. Method of enhancing differentiation and survival of neuronal precursor cells
NZ256018A (en) * 1992-09-25 1997-07-27 Rhone Poulenc Rorer Sa Recombinant adenoviral vectors and their use in directing expression and transcription of selected nucleotide sequences in cells of the central nervous system
FR2704234B1 (fr) * 1993-04-22 1995-07-21 Centre Nat Rech Scient Virus recombinants, preparation et utilisation en therapie genique.

Also Published As

Publication number Publication date
KR970701784A (ko) 1997-04-12
WO1995025804A1 (fr) 1995-09-28
FR2717496A1 (fr) 1995-09-22
FI963674A0 (fi) 1996-09-17
MX9603490A (es) 1997-03-29
FR2717496B1 (fr) 1996-04-12
AU1896295A (en) 1995-10-09
EP0750676A1 (fr) 1997-01-02
JPH09510358A (ja) 1997-10-21
CA2184200A1 (fr) 1995-09-28
NO963559L (no) 1996-08-26
IL112992A0 (en) 1995-06-29
ZA952244B (en) 1996-01-16
AU703793B2 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
AU2319497A (en) Helper-free, totally defective adenovirus for gene therapy
IL154542A0 (en) The neurotrophic factor nnt-1
GB9115909D0 (en) Recombinant dna
EP0797581A4 (en) NEW TYROSINE KINASE PROTEIN, JAK3
DE69739796D1 (de) Farbbildverarbeitung zwischen Auszügen mit Verwendung von Fehlerdiffusion
DE19781723T1 (de) Aufhängungssystem mit Ausrichtungsmechanismus
BR9700688A (pt) 2-oxo- e 2-tio-1,2-dihidroquinolinil-oxazolidinonas
ZA9710288B (en) Novel genes encoding telomerase proteins.
NO971347D0 (no) DNA som koder for humant papillomvirus type 6A
AU2672397A (en) AL-2 neurotrophic factor
DE59504180D1 (de) Ionenpermeable, Infrarot-reflektierende Elektrode
FI963674A (fi) Yhdistelmä-DNA-adenoviruksia, jotka koodittavat aivoperäistä neurotrofista tekijää (BDNF)
AU2677797A (en) Viral vectors including polynucleotides encoding neurotrophic factors and uses therefor
EP0763046A4 (en) DNA ENCODING GENE 1 OF GLUCAN SYNTHESIS
GB9421093D0 (en) Hippocampus-associated proteins, DNA sequences coding therefore and uses thereof
HUP0001969A3 (en) The neurotrophic factor nnt-1
NO901434D0 (no) Neurotrofiske peptider.
EP0958304A4 (en) NUCLEOTIDE SEQUENCE ENCODING PROTEIN TYPE CD33
DE9415089U1 (de) Zentralheizungsanlage
DE69738977D1 (de) Neues fusionsprotein, dafuer kodierendes gen, rekoerwendung
AU2076701A (en) Novel human transporter protein and polynucleotides encoding the same
NO20010088D0 (no) Neurotrofiske faktorer
IL140030A0 (en) Polypeptides dna molecules encoding them
GB9421464D0 (en) Recombinant DNA
ITPD940057A0 (it) Vetrata isolante riscaldante perfezionata.

Legal Events

Date Code Title Description
MA Patent expired